The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model

Schloer, S; Hübel, N; Masemann, D; Pajonczyk, D; Brunotte, L; Ehrhardt, C; Brandenburg, LO; Ludwig, S; Gerke, V; Rescher, U (2019)

In: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(11), 31398292.

Research article (journal)

Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection

Klemm C., Bruchhagen C., Van Krüchten A., Niemann S., Löffler B., Peters G., Ludwig S., Ehrhardt C. (2017)

In: Scientific Reports, 7(null).

Research article (journal)

The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo

Haasbach E., Müller C., Ehrhardt C., Schreiber A., Pleschka S., Ludwig S., Planz O. (2017)

In: Antiviral Research, 142(null).

Research article (journal)

Vemurafenib limits Influenza A Virus propagation by targeting multiple signaling pathways

In: .

Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity

In: .

Publications

Operated by

Top-Links

The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model Schloer, S; Hübel, N; Masemann, D; Pajonczyk, D; Brunotte, L; Ehrhardt, C; Brandenburg, LO; Ludwig, S; Gerke, V; Rescher, U (2019) In: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(11), 31398292. Research article (journal)
Immunomodulatory Nonstructural Proteins of Influenza A Viruses Klemm C., Boergeling Y., Ludwig S., Ehrhardt C. (2018) In: Trends in Microbiology, null(null). Research article (journal)
Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection Klemm C., Bruchhagen C., Van Krüchten A., Niemann S., Löffler B., Peters G., Ludwig S., Ehrhardt C. (2017) In: Scientific Reports, 7(null). Research article (journal)
Influenza A virus NS1 protein-induced JNK activation and apoptosis are not functionally linked Nacken W., Wixler V., Ehrhardt C., Ludwig S. (2017) In: Cellular Microbiology, null(null). Research article (journal)
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo Haasbach E., Müller C., Ehrhardt C., Schreiber A., Pleschka S., Ludwig S., Planz O. (2017) In: Antiviral Research, 142(null). Research article (journal)
Pharmacodynamics, pharmacokinetics, and antiviral activity of BAY 81-8781, a novel NF-κB inhibiting anti-influenza drug Droebner K., Haasbach E., Dudek S., Scheuch G., Nocker K., Canisius S., Ehrhardt C., von Degenfeld G., Ludwig S., Planz O. (2017) In: Frontiers in Microbiology, 8(null).
Vemurafenib limits Influenza A Virus propagation by targeting multiple signaling pathways In: .
Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stability In: .
Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity In: .
Super-infection with Staphylococcus aureus inhibits influenza virus-induced type I IFN signalling through impaired STAT1-STAT2 dimerization In: .